22 results
8-K
EX-1.1
apc s6ccfj
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
9mn5 qp9qnb
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
06va7fkja1 poou
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
utzfqxhrmledr
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
fkybsky9i
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
y70 jbd3r8f0u8
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
sgv548pbb 0bg
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
eb8oq eca73xw0q45gk
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-4.1
fdti uyeq
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
ns7y2f79f bxa
12 Apr 19
Prospectus supplement
4:39pm